| 1 day | -2.54% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2018-06-26 | |
Mark Oki
DFI | Director of Finance/CFO | 57 | - |
Margaret Cabano
COO | Chief Operating Officer | - | 2004-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 2018-06-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/19/21 | Issuer sale | Director | 204,808 | 0.4116% | ||
| 3/19/21 | Issuer sale | Director | 105,616 | 0.2123% | ||
| 3/19/21 | Issuer sale | Chief Financial Officer | 781,668 | 1.5709% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.54% | +24.18% | - | - | 49.26M | ||
| +0.02% | -3.52% | +36.11% | +111.11% | 1,019B | ||
| -1.21% | -6.99% | +34.08% | +60.96% | 617B | ||
| +1.12% | -0.20% | +13.62% | +80.24% | 464B | ||
| -3.30% | -6.15% | +56.45% | +34.69% | 356B | ||
| +0.93% | -1.83% | +21.65% | +41.43% | 333B | ||
| +0.12% | -4.05% | +10.70% | +33.53% | 267B | ||
| -0.89% | -5.83% | -7.00% | +7.91% | 244B | ||
| -0.01% | -3.62% | +35.28% | +52.02% | 218B | ||
| -0.08% | -4.98% | +28.34% | +93.61% | 179B | ||
| Average | -0.06% | -3.74% | +25.47% | +57.28% | 410.8B | |
| Weighted average by Cap. | +0.44% | -3.63% | +28.50% | +68.49% |
Employees
213
Sector
Pharmaceuticals
















